Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ness

Showing results (121-130 of 129) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 129 results.
Cancers|September 2, 2020
Oncogenic Orphan Nuclear Receptor NR4A3 Interacts and Cooperates with MYB in Acinic Cell CarcinomaDavid Y Lee, Kathryn J Brayer, Yoshitsugu Mitani, et al.
Leukemia|April 16, 2011
GSI-I (Z-LLNle-CHO) inhibits γ-secretase and the proteosome to trigger cell death in precursor-B acute lymphoblastic leukemiaX Meng, K Matlawska-Wasowska, F Girodon, et al.
Cancer Science|April 12, 2019
Epigenetic silencing of SOCS5 potentiates JAK-STAT signaling and progression of T-cell acute lymphoblastic leukemiaNitesh D Sharma, Christian K Nickl, Huining Kang, et al.
Cancers|March 11, 2023
Dominant Gene Expression Profiles Define Adenoid Cystic Carcinoma (ACC) from Different Tissues: Validation of a Gene Signature Classifier for Poor Survival in Salivary Gland ACCKathryn J Brayer, Huining Kang, Adel K El-Naggar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2021
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Washout Period and Concomitant Medication Work GroupR Donald Harvey, Kathryn F Mileham, Vishal Bhatnagar, et al.
Bioorganic & Medicinal Chemistry Letters|November 3, 2015
Development of a potent and selective cell penetrant Legumain inhibitorKerry A Ness, Sharon L Eddie, Catherine A Higgins, et al.
Elife|July 5, 2022
Genomic landscape of lymphatic malformations: a case series and response to the PI3Kα inhibitor alpelisib in an <i>N</i>-of-1 clinical trialMontaser F Shaheen, Julie Y Tse, Ethan S Sokol, et al.
Nature Communications|March 17, 2016
A phosphotyrosine switch regulates organic cation transportersJason A Sprowl, Su Sien Ong, Alice A Gibson, et al.
Leukemia|March 9, 2016
MLL rearrangements impact outcome in HOXA-deregulated T-lineage acute lymphoblastic leukemia: a Children's Oncology Group StudyK Matlawska-Wasowska, H Kang, M Devidas, et al.
Pageof 13

Showing results (121-130 of 129) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 129 results.
Cancers|September 2, 2020
Oncogenic Orphan Nuclear Receptor NR4A3 Interacts and Cooperates with MYB in Acinic Cell CarcinomaDavid Y Lee, Kathryn J Brayer, Yoshitsugu Mitani, et al.
Leukemia|April 16, 2011
GSI-I (Z-LLNle-CHO) inhibits γ-secretase and the proteosome to trigger cell death in precursor-B acute lymphoblastic leukemiaX Meng, K Matlawska-Wasowska, F Girodon, et al.
Cancer Science|April 12, 2019
Epigenetic silencing of SOCS5 potentiates JAK-STAT signaling and progression of T-cell acute lymphoblastic leukemiaNitesh D Sharma, Christian K Nickl, Huining Kang, et al.
Cancers|March 11, 2023
Dominant Gene Expression Profiles Define Adenoid Cystic Carcinoma (ACC) from Different Tissues: Validation of a Gene Signature Classifier for Poor Survival in Salivary Gland ACCKathryn J Brayer, Huining Kang, Adel K El-Naggar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2021
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Washout Period and Concomitant Medication Work GroupR Donald Harvey, Kathryn F Mileham, Vishal Bhatnagar, et al.
Bioorganic & Medicinal Chemistry Letters|November 3, 2015
Development of a potent and selective cell penetrant Legumain inhibitorKerry A Ness, Sharon L Eddie, Catherine A Higgins, et al.
Elife|July 5, 2022
Genomic landscape of lymphatic malformations: a case series and response to the PI3Kα inhibitor alpelisib in an <i>N</i>-of-1 clinical trialMontaser F Shaheen, Julie Y Tse, Ethan S Sokol, et al.
Nature Communications|March 17, 2016
A phosphotyrosine switch regulates organic cation transportersJason A Sprowl, Su Sien Ong, Alice A Gibson, et al.
Leukemia|March 9, 2016
MLL rearrangements impact outcome in HOXA-deregulated T-lineage acute lymphoblastic leukemia: a Children's Oncology Group StudyK Matlawska-Wasowska, H Kang, M Devidas, et al.
Pageof 13